{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:36:06Z","timestamp":1789799766277,"version":"4.0.1"},"reference-count":80,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Anemia of chronic diseases is a condition that accompanies a specific underlying disease, in which there is a decrease in hemoglobin, hematocrit and erythrocyte counts due to a complex process, usually initiated by cellular immunity mechanisms and pro-inflammatory cytokines and hepcidin. This is the second most common type of anemia after iron deficiency anemia in the world. Its severity generally correlates with the severity of the underlying disease. This disease most often coexists with chronic inflammation, autoimmune diseases, cancer, and kidney failure. Before starting treatment, one should undertake in-depth diagnostics, which includes not only assessment of complete blood count and biochemical parameters, but also severity of the underlying disease. The differential diagnosis of anemia of chronic diseases is primarily based on the exclusion of other types of anemia, in particular iron deficiency. The main features of anemia of chronic diseases include mild to moderate lowering of hemoglobin level, decreased percentage of reticulocyte count, low iron and transferrin concentration, but increased ferritin. Due to the increasingly better knowledge of the pathomechanism of chronic diseases and cancer biology, the diagnosis of this anemia is constantly expanding with new biochemical indicators. These include: the concentration of other hematopoietic factors (folic acid, vitamin B12), hepcidin, creatinine and erythropoietin. The basic form of treatment of anemia of chronic diseases remains supplementation with iron, folic acid and vitamin B12 as well as a diet rich in the above-mentioned hematopoietic factors. The route of administration (oral, intramuscular or intravenous) requires careful consideration of the benefits and possible side effects, and assessment of the patient\u2019s clinical status. New methods of treating both the underlying disease and anemia are raising hopes. The novel methods are associated not only with supplementing deficiencies, but also with the administration of drugs molecularly targeted to specific proteins or receptors involved in the development of anemia of chronic diseases.<\/jats:p>","DOI":"10.3390\/nu12061784","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:50:49Z","timestamp":1592268649000},"page":"1784","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Anemia of Chronic Diseases: Wider Diagnostics\u2014Better Treatment?"],"prefix":"10.3390","volume":"12","author":[{"given":"Micha\u0142","family":"Wici\u0144ski","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Curie 9, 85-090 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3505-3295","authenticated-orcid":false,"given":"Grzegorz","family":"Liczner","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Curie 9, 85-090 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Cadelski","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Curie 9, 85-090 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadeusz","family":"Ko\u0142nierzak","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Curie 9, 85-090 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2304-2903","authenticated-orcid":false,"given":"Magdalena","family":"Nowaczewska","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Head and Neck Surgery, and Laryngological Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Curie 9, 85-090 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Malinowski","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Curie 9, 85-090 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1056\/NEJMra052706","article-title":"Lineage-specific hematopoietic growth factors","volume":"354","author":"Kaushansky","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2141.2008.07014.x","article-title":"The non-haematopoietic biological effects of erythropoietin","volume":"141","author":"Arcasoy","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/bjh.13133","article-title":"Novel antibodies directed against the human erythropoietin receptor: Creating a basis for clinical implementation","volume":"168","author":"Maxwell","year":"2015","journal-title":"Br. J. Haematol"},{"key":"ref_4","first-page":"164","article-title":"Review on iron and its importance for human health","volume":"19","author":"Abbaspour","year":"2014","journal-title":"J. Res. Med. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Imam, M.U., Zhang, S., Ma, J., Wang, H., and Wang, F. (2017). Antioxidants Mediate Both Iron Homeostasis and Oxidative Stress. Nutrients, 9.","DOI":"10.3390\/nu9070671"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3164\/jcbn.09-46","article-title":"Dietary intake and serum levels of iron in relation to oxidative stress in breast cancer patient","volume":"45","year":"2009","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Chiou, B., and Connor, J.R. (2018). Emerging and Dynamic Biomedical Uses of Ferritin. Pharmaceuticals (Basel), 11.","DOI":"10.3390\/ph11040124"},{"key":"ref_8","first-page":"9394060","article-title":"Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions","volume":"2018","author":"Dignass","year":"2018","journal-title":"Int. J. Chronic Dis."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Santana-Codina, N., and Mancias, J.D. (2018). The Role of NCOA4-Mediated Ferritinophagy in Health and Disease. Pharmaceiticals (Basel), 11.","DOI":"10.20944\/preprints201809.0148.v1"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.celrep.2015.12.065","article-title":"NCOA4 Deficiency Impairs Systemic Iron Homeostasis","volume":"14","author":"Bellelli","year":"2016","journal-title":"Cell Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1126\/science.1057206","article-title":"An Iron-Regulated Ferric Reductase Associated with the Absorption of Dietary Iron","volume":"291","author":"McKie","year":"2001","journal-title":"Science"},{"key":"ref_12","first-page":"318","article-title":"Evidence that bile salts are important for iron absorption","volume":"266","author":"Sanyal","year":"1994","journal-title":"Am. J. Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/0016-5085(92)90325-S","article-title":"High-affinity Binding Is Essential for Enhancement of Intestinal Fe2+ and Ca2+ Uptake by Bile Salts","volume":"102","author":"Sanyal","year":"1992","journal-title":"Gastroenterology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","article-title":"Hepcidin and Iron homeostasis","volume":"1823","author":"Ganz","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"24155","DOI":"10.1074\/jbc.M109.017764","article-title":"Hepcidin Revisited, Disulfide Connectivity, Dynamics, and Structure","volume":"284","author":"Jordan","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jada.2011.08.038","article-title":"Rethinking Iron Regulation and Assessment in Iron Deficiency, Anemia of Chronic Disease, and Obesity: Introducing Hepcidin","volume":"112","author":"Pustacioglu","year":"2012","journal-title":"J. Acad. Nutr. Diet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0268-960X(03)00066-3","article-title":"Hepcidin and Anaemia","volume":"18","author":"Means","year":"2004","journal-title":"Blood Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000362888","article-title":"Physiology of Iron Metabolism","volume":"41","author":"Sophie","year":"2014","journal-title":"Transfus. Med. Hemother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbagen.2011.10.013","article-title":"Regulation of Iron Transport and the Role of Transferrin","volume":"1820","author":"Gkouvatsos","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/563251","article-title":"Management of Anemia of Inflammation in the Elderly","volume":"2012","author":"Maccio","year":"2012","journal-title":"Anemia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/nu5030957","article-title":"Regulatory Effects of Cu, Zn, and Ca on Fe Absorption: The Intricate Play between Nutrient Transporters","volume":"5","author":"Scheers","year":"2013","journal-title":"Nutrients"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.bbagen.2008.04.003","article-title":"Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents","volume":"1790","author":"Richardson","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1359-6446(04)03333-1","article-title":"Transferrin: Structure, function and potential therapeutic actions","volume":"10","author":"Gomme","year":"2005","journal-title":"Drug Disc. Tod."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MOH.0000000000000494","article-title":"New insights into the links between hypoxia and iron homeostasis","volume":"26","author":"Renassia","year":"2019","journal-title":"Curr. Opin. Hematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible Factors in Physiology and Medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1074\/jbc.272.9.5375","article-title":"Hypoxia-inducible factor-1 Mediates Transcriptional Activation of the Heme oxygenase-1 Gene in Response to Hypoxia","volume":"272","author":"Lee","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"24142","DOI":"10.1074\/jbc.274.34.24142","article-title":"Transferrin Receptor Induction by Hypoxia. HIF-1-mediated Transcriptional Activation and Cell-Specific Post-Transcriptional Regulation","volume":"274","author":"Tacchini","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1172\/JCI30117","article-title":"Hypoxia-inducible factor-2 (HIF-2) Regulates Hepatic Erythropoietin In Vivo","volume":"117","author":"Rankin","year":"2007","journal-title":"J. Clin. Invest."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1182\/blood-2012-11-427765","article-title":"The gut in iron homeostasis: Role of HIF-2 under normal and pathological conditions","volume":"122","author":"Mastrogiannaki","year":"2013","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/13543784.2018.1493455","article-title":"Investigational Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHI) for the Treatment of Anemia Associated with Chronic Kidney Disease","volume":"27","author":"Locatelli","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00000421-200208000-00011","article-title":"Anemia in oncology practice: Relation to diseases and their therapies","volume":"25","author":"Tas","year":"2002","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1528::AID-CNCR20>3.0.CO;2-E","article-title":"The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix","volume":"86","author":"Grogan","year":"1999","journal-title":"Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P","article-title":"Anemia as an independent prognostic factor for survival in patients with cancer: A systemic, quantitative review","volume":"91","author":"Caro","year":"2001","journal-title":"Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0360-3016(98)00348-4","article-title":"Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: A secondary analysis of RTOG 85-27","volume":"42","author":"Lee","year":"1998","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3324\/haematol.2009.013615","article-title":"Serum hepcidin: A novel diagnostic tool in disorders of iron metabolism","volume":"94","author":"Bergamaschi","year":"2009","journal-title":"Haematologica"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/labinvest.3700553","article-title":"Changes of gene expression of iron regulatory proteins during turpentine oil-induced acute-phase response in the rat","volume":"87","author":"Sheikh","year":"2007","journal-title":"Lab. Investig."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/jir.1998.18.555","article-title":"Proinflammatory cytokines lowering erythropoietin production","volume":"18","author":"Jelkmann","year":"1998","journal-title":"J. Interferon Cyt. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood.V79.8.1987.1987","article-title":"Effect of inflammatory cytokines on hypoxia-induced erythropoietin production","volume":"79","author":"Faquin","year":"1992","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1200\/JCO.2006.08.1190","article-title":"Understanding the presence and function of erythropoietin receptors on cancer cells","volume":"24","author":"Lai","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_41","first-page":"3561","article-title":"Erythropoietin and erythropoietin receptor expression in human cancer","volume":"61","author":"Acs","year":"2001","journal-title":"Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/carcin\/23.11.1797","article-title":"Erythropoietin is involved in growth and angiogenesis in malignant tumours of female reproductive organs","volume":"23","author":"Yasuda","year":"2002","journal-title":"Carcinogenesis"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1186\/cc9408","article-title":"Inflammation\u2014Induced hepcidin-25 is associated with the development of anemia in septic patients: An observational study","volume":"15","author":"Kroot","year":"2011","journal-title":"Crit. Care"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3324\/haematol.2009.019331","article-title":"Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria","volume":"95","author":"Syafruddin","year":"2010","journal-title":"Haematologica"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"44S","DOI":"10.1016\/j.amjmed.2003.12.011","article-title":"Prevalence and outcomes of anemia in inflammatory bowel disease: A systemic review of the literature","volume":"116","author":"Wilson","year":"2004","journal-title":"J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1034\/j.1399-0012.2001.150507.x","article-title":"Characteristics and clinical relevance of chronic anemia in adult heart transplant recipient","volume":"15","author":"Horina","year":"2001","journal-title":"Clin. Transpl."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2141.2011.08741.x","article-title":"Diagnosis and management of anemia of chronic disease: Current status","volume":"154","author":"Cullis","year":"2011","journal-title":"Br. J. Haematol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000452104","article-title":"Anaemia of Chronic Disease: An In-Depth Review","volume":"26","author":"Madu","year":"2017","journal-title":"Med. Princ. Pract."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/00365599.2012.685492","article-title":"Anaemia treatment in chronically dialysed children: A multicentre nationwide observational study","volume":"46","author":"Jander","year":"2012","journal-title":"Scand. J. Urol. Nephrol."},{"key":"ref_50","first-page":"198","article-title":"Recombinant human erythropoietin in treatment of the cancer patients with anemia: Hopes and threats","volume":"3","author":"Winczura","year":"2007","journal-title":"Oncol. Clin. Pract."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.blre.2011.10.003","article-title":"The investigation and treatment of secondary anaemia","volume":"26","author":"Davis","year":"2012","journal-title":"Blood Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/248430","article-title":"Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study","volume":"2012","author":"Joshi","year":"2012","journal-title":"Anaemia"},{"key":"ref_53","first-page":"1","article-title":"Anemia of inflammation in older persons. Part II. Impact of age-dependent diseases, diagnostic and therapeutic options","volume":"7","year":"2013","journal-title":"Geriatria"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00296-009-1075-4","article-title":"Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production","volume":"30","author":"Hashizume","year":"2010","journal-title":"Rheumatol. Int."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Hashimoto, M., Fujii, T., Hamaguchi, M., Furu, M., Ito, H., Terao, C., Yamamoto, K., Yamamoto, W., Matsuo, T., and Mori, M. (2014). Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0098202"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2009-09-245977","article-title":"Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation- induced anaemia","volume":"115","author":"Sasu","year":"2010","journal-title":"Blood"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2215\/CJN.08161109","article-title":"Reduction of serum hepcidin by hemodialysis in pediatric and adult patients","volume":"5","author":"Zaritsky","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0171-2985(86)80101-2","article-title":"Characterization and biological effects of recombinant human erythropoietin","volume":"172","author":"Egrie","year":"1986","journal-title":"Immunobiology"},{"key":"ref_59","first-page":"13","article-title":"Development ad characterization of darbepoetin alfa","volume":"16","author":"Egrie","year":"2002","journal-title":"Oncology"},{"key":"ref_60","first-page":"65","article-title":"Folic acid\u2014effects of deficiency and justification for supplementation","volume":"18","author":"Skrzypczak","year":"2012","journal-title":"Med. Og\u00f3lna i Nauki o Zdrowiu."},{"key":"ref_61","first-page":"17","article-title":"Witamina B12\u2014budowa, biosynteza, funkcje i metody oznaczania","volume":"5","author":"Czaczyk","year":"2010","journal-title":"\u017byw. N. Tech. Jak."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000085049","article-title":"Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis","volume":"100","author":"Charytan","year":"2005","journal-title":"Nephron. Clin. Pract."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1021\/jf0203040","article-title":"Organic acids influence iron uptake in the human epithelial cell line caco-2","volume":"50","author":"Salovaara","year":"2002","journal-title":"J. Agric. Food Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.copbio.2011.08.007","article-title":"Polyphenols as Antimicrobial Agents","volume":"23","author":"Daglia","year":"2012","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.chom.2009.03.011","article-title":"Lipocalin-2 Resistance Confers an Advantage to Salmonella Enterica Serotype Typhimurium for Growth and Survival in the Inflamed Intestine","volume":"5","author":"Raffatellu","year":"2009","journal-title":"Cell Host Microbe"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/MIB.0000000000001089","article-title":"Iron Supplements Modulate Colon Microbiota Composition and Potentiate the Protective Effects of Probiotics in Dextran Sodium Sulfate-induced Colitis","volume":"23","author":"Constante","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fmed.2018.00109","article-title":"Immune Cells and Microbiota Response to Iron Starvation","volume":"5","author":"Chieppa","year":"2018","journal-title":"Front Med. (Lausanne)"},{"key":"ref_68","first-page":"195","article-title":"Oral iron supplementation in renal anemia","volume":"5","year":"2012","journal-title":"For. Nefrol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/ndt\/gfq613","article-title":"A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients","volume":"26","author":"Quinibi","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1185\/03007990903512461","article-title":"Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: Oral or intravenous?","volume":"26","author":"Macdougall","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1634\/theoncologist.2011-S3-25","article-title":"Iron supplementation in nephrology and oncology: What do we have in common?","volume":"16","author":"Macdougall","year":"2011","journal-title":"Oncologist"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ajcn\/85.1.3","article-title":"Folic acid fortification: The good, the bad, and the puzzle of vitamin B-12","volume":"85","author":"Smith","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood-2010-06-289082","article-title":"Heparin: A potent inhibitor of hepcidin expression in vitro and in vivo","volume":"117","author":"Poli","year":"2011","journal-title":"Blood"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.335","article-title":"BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism","volume":"41","author":"Andriopoulos","year":"2009","journal-title":"Nat. Gen."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/rheumatology\/kes381","article-title":"Effect of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: Results of a phase 1, randomized, open-label trial","volume":"52","author":"Doyle","year":"2013","journal-title":"Rheumatology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1517\/14712598.2011.627850","article-title":"A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer","volume":"11","author":"Bayliss","year":"2011","journal-title":"Exp. Opin. Biol. Ther."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/mol.112.083428","article-title":"High-throughput screening of small molecules identifies hepcidin antagonists","volume":"83","author":"Fung","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1021\/js970246a","article-title":"Transferrin conjugates of doxorubicin: Synthesis, characterization, cellular uptake, and in vitro efficacy","volume":"87","author":"Kratz","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1124\/mol.105.013383","article-title":"Molecular pharmacology of the interaction of anthracyclines with iron","volume":"68","author":"Xu","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1021\/acs.jmedchem.7b01686","article-title":"Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases","volume":"61","author":"Joharapurkar","year":"2018","journal-title":"J. Med. Chem."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/6\/1784\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:39:20Z","timestamp":1760175560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/6\/1784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":80,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["nu12061784"],"URL":"https:\/\/doi.org\/10.3390\/nu12061784","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,16]]}}}